Status:
TERMINATED
A Penicillin Allergy Delabeling Inhospital Model Hospitalized Patients
Lead Sponsor:
Althaia Xarxa Assistencial Universitària de Manresa
Conditions:
Evaluation and Management Model for Beta-lactam Allergy in Hospitalized Patients
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Design, implementation and analysis of an allergy assessment and management model beta-lactams in hospitalized patients
Detailed Description
To evaluate the impact of a healthcare process for risk stratification based on the clinical history and the application of a structured questionnaire, on the Proportion of hospitalized patients in wh...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Age \> 18 years
- Ability to understand the study after reading the patient information sheet (Appendix II) and providing signed consent for participation (Appendix III: informed consent form).
- Patients with a reported allergy to penicillin and/or cephalosporins that has not been investigated or with inconclusive prior testing.
- Exclusion Criteria
- \- None
Exclusion
Key Trial Info
Start Date :
April 4 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 25 2025
Estimated Enrollment :
165 Patients enrolled
Trial Details
Trial ID
NCT07194824
Start Date
April 4 2024
End Date
May 25 2025
Last Update
September 26 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Althaia
Manresa, Barcelona, Spain, 08243
2
C/ dr.Joan Soler 1-3
Manresa, Barcelona, Spain, 08243